Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,520.64
    -1,022.66 (-1.98%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Analysts Favor ‘Buy’ for Altria

Analysts Favor ‘Buy’ for Altria

As of July 2, Altria Group (MO) was trading at $55.80, and analysts’ 12-month stock price target was $68.57, implying a 22.7% return. On June 26, Morgan Stanley cut its target price from $65 to $63, while Jefferies lowered its target price from $84 to $70 on June 1. Since Altria’s first-quarter earnings announcement, Deutsche Bank, Citigroup, and Berenberg have lowered their price targets for its stock. The dip of 4.2% in Altria’s cigarette shipment volumes and increasing restrictions on tobacco products appear to have prompted analysts to lower their price targets.